0001209191-17-021699.txt : 20170320 0001209191-17-021699.hdr.sgml : 20170320 20170320161049 ACCESSION NUMBER: 0001209191-17-021699 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170316 FILED AS OF DATE: 20170320 DATE AS OF CHANGE: 20170320 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRIEDMAN PAUL A CENTRAL INDEX KEY: 0001236927 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 17701520 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION STREET 2: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-16 0 0000879169 INCYTE CORP INCY 0001236927 FRIEDMAN PAUL A 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 1 0 0 0 Common Stock 2017-03-16 4 M 0 5458 18.32 A 302976 D Common Stock 2017-03-16 4 M 0 2849 18.32 A 305825 D Common Stock 2017-03-16 4 S 0 8307 151.45 D 297518 D Common Stock 2017-03-17 4 M 0 41693 18.32 A 339211 D Common Stock 2017-03-17 4 S 0 41693 148.18 D 297518 D Non-Qualified Stock Option (right to buy) 18.32 2017-03-16 4 M 0 5458 0.00 D 2020-02-08 Common Stock 5458 0 D Non-Qualified Stock Option (right to buy) 18.32 2017-03-16 4 M 0 2849 0.00 D 2020-02-08 Common Stock 2849 141693 D Non-Qualified Stock Option (right to buy) 18.32 2017-03-17 4 M 0 41693 0.00 D 2020-02-08 Common Stock 41693 100000 D Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated. Represents weighted average sale price. Actual sale prices ranged from $151.09 - $151.75. Represents weighted average sale price. Actual sale prices ranged from $148.00 - $148.92. Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ Paul A. Friedman 2017-03-20